Agios Pharmaceuticals (AGIO) Stock
Agios Pharmaceuticals (AGIO) closed at $31.59 on Nov 13, 2026; its Tenet Score is 64 of 100 against 409 Healthcare peers.
20 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $31.59
- Nov 13, 2026
- Market cap
- $1.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 22.24 – 46.00
- low → high
- Tenet Score
- 64/100
- Solid · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Agios Pharmaceuticals Inc scores 64/100. Solid. Strongest on financial health and value versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a v…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Vera Therapeutics IncVERA | 36 | $2.0B |
| Zymeworks BC IncZYME | 48 | $2.0B |
| Recursion Pharmaceuticals IncRXRX | 55 | $2.0B |
| Harmony Biosciences Holdings IncHRMY | 81 | $2.0B |
| Veracyte IncVCYT | 77 | $2.0B |
| Maravai LifeSciences Holdings IncMRVI | 29 | $2.0B |
| Biocryst Pharmaceuticals Inc.BCRX | 73 | $2.0B |
| Damora Therapeutics Inc.DMRA | 47 | $1.9B |
| Eton Pharmaceuticals IncETON | 45 | $1.8B |
| Certara IncCERT | 52 | $1.8B |
Common questions
What sector and industry is Agios Pharmaceuticals in?
Agios Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Agios Pharmaceuticals' Tenet Score?
Agios Pharmaceuticals' Tenet Score is 64 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




